Anti-inflammatory Respiratory Agents

Anti-inflammatory Respiratory Agents

Anti-inflammatory Respiratory Agents

On this page

Corticosteroids - Steroid Power Puffs

Potent anti-inflammatory; cornerstone of asthma/COPD therapy.

  • MOA: Bind intracellular glucocorticoid receptors → modulate gene expression → ↓ inflammatory mediators (cytokines, PGs, LTs) & ↓ inflammatory cell activity.
  • Key Examples:
    • ICS (Inhaled): Beclomethasone, Budesonide, Fluticasone.
    • Systemic: Prednisolone, Hydrocortisone.
  • Major Indications:
    • Asthma: First-line controller for persistent disease.
    • COPD: Exacerbations, severe disease (often with LABA).
  • Side Effects & Pearls:
    • ICS: Oral candidiasis (thrush), dysphonia. 💡 Pearl: Use spacer; rinse mouth post-ICS to prevent.
    • Systemic (long-term): Cushingoid features, osteoporosis, hyperglycemia, PUD, immunosuppression. 📌 Mnemonic for systemic effects: CUSHINGOID (multiple features).

⭐ Inhaled corticosteroids (ICS) are the most effective long-term control therapy for persistent asthma. Factors affecting glucocorticoid sensitivity in asthmaoka

Leukotriene Modifiers - Leukotriene Block Party

Leukotriene synthesis pathway and drug targets

  • Overview: Target leukotrienes, key inflammatory mediators in asthma.
  • Classes & MOA:
    • Zileuton: 5-Lipoxygenase (5-LOX) inhibitor. Blocks synthesis of all leukotrienes.
      • Indication: Chronic asthma.
      • ⚠️ Side Effect: Hepatotoxicity (monitor LFTs).
    • Montelukast, Zafirlukast: Cysteinyl Leukotriene Receptor Antagonists (LTRAs). Block CysLT1 receptors. 📌 LUKasts block LeUKotriene receptors.
      • Indications: Add-on asthma therapy, Aspirin-Exacerbated Respiratory Disease (AERD), exercise-induced bronchoconstriction.
      • ⚠️ Side Effects: Montelukast: Neuropsychiatric events. Zafirlukast: Hepatotoxicity, Churg-Strauss (rare).

⭐ Montelukast is particularly useful in patients with aspirin-exacerbated respiratory disease (AERD) due to its effect on cysteinyl leukotrienes.

Mast Cell Stabilizers & Anti-IgE - Allergy Avengers

  • Mast Cell Stabilizers: Cromolyn, Nedocromil
    • MOA: Stabilize mast cells → ↓ degranulation & mediator release.
    • Use: Prophylaxis (mild asthma/allergic rhinitis). Not for acute attacks. Limited efficacy.
  • Anti-IgE Antibody: Omalizumab (📌 OMA binds IgE)
    • MOA: Monoclonal Ab; binds free IgE → prevents mast cell activation.
    • Indication: Severe allergic asthma (IgE 30-700 IU/mL), ≥6 yrs.
    • Route: Subcutaneous. ⚠️ Key SE: Anaphylaxis.
FeatureCromolynsOmalizumab
MOA Detail↓ Mediator release↓ IgE binding to mast cells
EfficacyLimitedEffective for severe IgE-mediated asthma
AdminInhalation/NasalSubcutaneous

⭐ Omalizumab is a monoclonal antibody that binds to free IgE, preventing its interaction with mast cells, and is used in severe, persistent allergic asthma.

PDE4 Inhibitors & Novel Agents - COPD's New Guard

  • Roflumilast (PDE4 Inhibitor):
    • MOA: $↑cAMP$ in inflammatory cells.
    • Indication: Severe COPD + chronic bronchitis & exacerbations.
    • Side Effects: GI distress, weight loss, mood changes (📌 Roflumilast: Mood, Intestinal, Loss of weight).
  • Novel Biologics (Anti-IL5 for Eosinophilic Asthma):
    • Mepolizumab, Reslizumab, Benralizumab.

⭐ Roflumilast: oral PDE4 inhibitor for severe COPD (chronic bronchitis, frequent exacerbations), reduces exacerbations.

High‑Yield Points - ⚡ Biggest Takeaways

  • Inhaled Corticosteroids (ICS) are first-line therapy for persistent asthma control.
  • Oropharyngeal candidiasis, dysphonia: key local ICS adverse effects; prevent with spacer use & mouth rinsing.
  • Systemic corticosteroids are vital for acute severe asthma exacerbations, reducing airway inflammation.
  • Montelukast (LTRA) is key for AERD and exercise-induced bronchoconstriction (EIB).
  • Mast cell stabilizers (e.g., Cromolyn) prevent mediator release, for asthma prophylaxis only.
  • Omalizumab (anti-IgE MAb) treats severe, persistent IgE-mediated allergic asthma.
  • Anti-IL-5 biologics (e.g., Mepolizumab) target eosinophils in severe eosinophilic asthma.

Practice Questions: Anti-inflammatory Respiratory Agents

Test your understanding with these related questions

In a patient with COPD, what is the best management option?

1 of 5

Flashcards: Anti-inflammatory Respiratory Agents

1/9

_____ and Nedocromil prevent mast cell degranulation (used for asthma prophylaxis)

TAP TO REVEAL ANSWER

_____ and Nedocromil prevent mast cell degranulation (used for asthma prophylaxis)

Cromolyn sodium

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial